MYOZ1
MYOZ1geneMYOZ1 influences cardiomyocyte structural adaptation and remodeling in response to ischemic injury and heart failure.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencelow
RationaleHF-specific remodeling candidate; plausibly reflects cardiomyocyte injury/remodeling rather than atherothrombotic cascade.
Druggability
DruggableNo
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableNo
EnsemblENSG00000177791
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- Shared Genetic Liability Between Heart Failure and Myocardial Infarction Revealed by Genome-Wide Cross-Trait Analysis.Journal of cardiovascular pharmacology and therapeutics · 2026 · PMID 42141940 · doi